685 results on '"Tse, Eric"'
Search Results
102. Arsenic trioxide targets Hsp60, triggering degradation of p53 and survivin
103. PIN1 overexpression and β-catenin gene mutations are distinct oncogenic events in human hepatocellular carcinoma
104. Practical considerations for using K3 cameras in CDS mode for high-resolution and high-throughput single particle cryo-EM
105. C3 Inhibition with Pegcetacoplan in Patients with Paroxysmal Nocturnal Hemoglobinuria: Results from the Paddock and Palomino Trials
106. Rapid deployment of SARS-CoV-2 testing: The CLIAHUB
107. Primary treatment of leukemia relapses after allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning second transplantation from the original donor
108. Deficiency of the Cyclin-Dependent Kinase Inhibitor, CDKN1B, Results in Overgrowth and Neurodevelopmental Delay
109. Multiplex Single‐Cell Analysis of Cancer Cells Enables Unbiased Uncovering Subsets Associated with Cancer Relapse: Heterogeneity of Multidrug Resistance in Precursor B‐ALL.
110. Molecular pathways in hepatocellular carcinoma
111. T-cell prolymphocytic leukaemia: spontaneous immunophenotypical switch from CD4 to CD8 expression
112. Post-transplant lymphoproliferative diseases in Asian solid organ transplant recipients: late onset and favorable response to treatment
113. Type II enteropathy-associated T-cell lymphoma: A multicenter analysis from the Asia Lymphoma Study Group
114. Characterization of the Lmo4 gene encoding a LIM-only protein: genomic organization and comparative chromosomal mapping
115. Synchronous Epstein–Barr virus-positive diffuse large B-cell lymphoma of the elderly and Epstein–Barr virus-positive classical Hodgkin lymphoma
116. Primary immune thrombocytopenia responding to antithyroid treatment in a patient with Gravesʼ disease
117. Low‐dose pembrolizumab and nivolumab were efficacious and safe in relapsed and refractory classical Hodgkin lymphoma: Experience in a resource‐constrained setting
118. Practical Considerations of Using the K3 Camera in CDS Mode for High-resolution and High-throughput Single Particle Cryo-EM
119. Oral arsenic trioxide, all‐ trans retinoic acid, and ascorbic acid maintenance after first complete remission in acute promyelocytic leukemia: Long‐term results and unique prognostic indicators
120. Risk assessment of venous thromboembolism in hematological cancer patients: a review
121. Targeting PIN1 as a Therapeutic Approach for Hepatocellular Carcinoma
122. Non-nasal natural killer cell lymphoma: not non-nasal after all
123. Whole Exome and Transcriptome Sequencing in 1042 Cases Reveals Distinct Clinically Relevant Genetic Subgroups of Follicular Lymphoma
124. Conformational Plasticity of the ClpAP AAA+ Protease Couples Protein Unfolding and Proteolysis
125. Persistent neutropenia in chronic myelogenous leukemia in chronic phase treated with imatinib mesylate
126. Plot 1
127. Gene related to Lung Fibrosis
128. IL1 and Lung Cancer
129. Regular Virologic Surveillance Showed Very Frequent Cytomegalovirus Reactivation in Patients Treated With Alemtuzumab
130. Subarachnoid haemorrhage: more than meets the eye
131. Natural Killer Cell Neoplasms
132. Fludarabine, mitoxantrone and dexamethasone in the treatment of indolent B- and T-cell lymphoid malignancies in Chinese patients
133. Treatment outcome and prognostic factor analysis in transplant-eligible Chinese myeloma patients receiving bortezomib-based induction regimens including the staged approach, PAD or VTD
134. Recurrent PD-L1 Structural Rearrangements in Natural Killer/T Cell Lymphoma Patients with Complete Response to PD-1 Blockade Therapy
135. Recent advances in the diagnosis and treatment of natural killer/T-cell lymphomas
136. Mechanistic Insights into the Protective Roles of Polyphosphate Against Amyloid Cytotoxicity
137. Compromised function of the ESCRT pathway promotes endolysosomal escape of tau seeds and propagation of tau aggregation
138. Rapid versus gradual lung function decline in bronchiolitis obliterans syndrome after haematopoietic stem cell transplantation is associated with survival outcome
139. Inhibition of C3 with APL-2 Results in Normalisation of Markers of Intravascular and Extravascular Hemolysis in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)
140. PIN1 in Cell Cycle Control and Cancer
141. Competing protein-protein interactions regulate binding of Hsp27 to its client protein tau
142. Polyphosphate Stabilizes Protein Unfolding Intermediates as Soluble Amyloid-like Oligomers
143. IL-17A is increased in the serum and in spinal cord CD8 and mast cells of ALS patients
144. PD1 blockade with pembrolizumab is highly effective in relapsed or refractory NK/T-cell lymphoma failing l-asparaginase
145. Chidamide in the treatment of peripheral T-cell lymphoma
146. Deficiency of Cks1 leads to learning and long-term memory defects and p27 dependentformation of neuronal cofilin aggregates
147. Structural basis for substrate gripping and translocation by the ClpB AAA+ disaggregase
148. Cell Cycle-Dependent Uptake and Cytotoxicity of Arsenic-Based Drugs in Single Leukemia Cells
149. Long-term outcome of relapsed acute promyelocytic leukemia treated with oral arsenic trioxide-based reinduction and maintenance regimens: A 15-year prospective study
150. X-linked inhibitor of apoptosis protein (XIAP) is a client of heat shock protein 70 (Hsp70) and a biomarker of its inhibition
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.